Delivery Order SPE2DR25D3801-SPE2DR26F6QDV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,341.23 to AmerisourceBergen Drug Corp for the supply of Hydroxychloroquine 200 mg tablets (100-count units) on November 25, 2025. This is a firm fixed price delivery order with an ultimate completion date of November 26, 2025, with performance to be executed at the awardee's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,492 units of Hydroxychloroquine 200 mg tablets in 100-count bottles. The contract has a potential value of $1,240.87 and a completion date of January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,416.50 to Amerisourcebergen Drug Corporation for 200 milligram tablets of hydroxychloroquine. Amerisourcebergen will deliver 100 tablets of the medication to a location in Conshohocken, Pennsylvania by July 18, 2023 in fulfillment of the contract. As a major division of Amerisourcebergen Corporation, the prime contractor will utilize its extensive distribution network to provide this...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,558,464 tablets of Hydroxychloroquine 200 mg. The $2,909.44 firm fixed-price contract has a completion date of September 15, 2022. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical...
- The Defense Logistics Agency awarded a $804.96 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division on July 20, 2023 for the provision of 100 tablets of 200 mg hydroxychloroquine. The place of performance is Conshohocken, Pennsylvania. No additional details were provided regarding the original solicitation or whether this delivery order is associated with any larger indefinite delivery/indefinite quantity contract vehicles. The single prime contractor is...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,817 to Amerisourcebergen Drug Corporation for the supply of 200 milligram hydroxychloroquine tablets. Under this contract, Amerisourcebergen will deliver 100 tablets of the specified medication to a location in Conshohocken, Pennsylvania by August 17, 2023 to fulfill requirements on behalf of the Defense Logistics Agency. No set aside designation or subcontracting arrangements were indicated. The...
- The Defense Logistics Agency Troop Support Medical awarded a $2,000 firm fixed price delivery order to Amerisourcebergen Drug Corp for 200mg hydroxychloroquine tablets. The order is for 100 tablets to be delivered by September 14, 2023 from Amerisourcebergen's facility in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp is a division of Amerisourcebergen Corporation, a major pharmaceutical distributor that frequently supports DLA's medical supply chain requirements. No subcontractors or...
- The Defense Logistics Agency awarded a $4,638.91 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 200 milligram hydroxychloroquine tablets. Under this contract, Amerisourcebergen will deliver 100 units of the specified pharmaceutical to a facility located in Conshohocken, Pennsylvania by August 17, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics network and supply chain, procuring a wide range of goods and services to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,561,984,356 units of hydroxychloroquine 200 mg tablets. The contract, valued at $1,539.32, is a firm fixed-price delivery order with an ultimate completion date of August 30, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
- The Defense Logistics Agency awarded a $166,180 delivery order to Amerisourcebergen Drug Corporation for hydroxychloroquine sulfate tablets. Under the terms of the firm fixed price contract, Amerisourcebergen will provide 100,000 tablets of the 200mg drug to a location in Conshohocken, Pennsylvania by August 18, 2023. No additional details were provided regarding the original solicitation or whether this award was issued against an existing indefinite-delivery/indefinite-quantity contract...
- SPE2DR25D3801Indefinite Delivery Contract
- SPE2DR25D3801-SPE2DR26F6QDVDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Hydroxychloroquine 200 mg, with a contract value of $2,780.34 and a firm fixed price structure. This non-competitive delivery order, issued on December 12, 2025, is due for completion by December 15, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement from the company's existing Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves as a prime contractor to the Defense Logistics Agency's Medical Supply Chain, supporting military and veteran healthcare systems. The company maintains an extensive portfolio of pharmaceutical deliveries under its DLA contract vehicle, spanning generic and brand-name medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Hydroxychloroquine represents a routine fulfillment of the company's broader role as a global pharmaceutical prime vendor supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 12/11/25 |